Endometriosis Is Undervalued: A Call to Action

Endometriosis is an inflammatory chronic pain condition caused by uterine tissue growing outside of the uterus that afflicts at least 11% of women (and people assigned female at birth) worldwide. This condition results in a substantial burden to these women, and society at large. Although endometrio...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Frontiers in Global Women's Health Ročník 3; s. 902371
Hlavní autoři:	Ellis, Katherine, Munro, Deborah, Clarke, Jennifer
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media SA 10.05.2022 Frontiers Media S.A
Témata:	Abdomen chronic pain Costs Crohn's disease Diabetes Diarrhea Endometriosis Females Fertility Funding Global Women's Health Health care expenditures Infertility Inflammatory diseases Irritable bowel syndrome Medical diagnosis Ovarian cancer Pain Patients Physiology Productivity Quality of life Sexual disorders Uterus women's health Womens health Australia United States > US endometriosis chronic pain funding quality of life women's health
ISSN:	2673-5059, 2673-5059
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Endometriosis is an inflammatory chronic pain condition caused by uterine tissue growing outside of the uterus that afflicts at least 11% of women (and people assigned female at birth) worldwide. This condition results in a substantial burden to these women, and society at large. Although endometriosis was first identified over 160 years ago, substantial knowledge gaps remain, including confirmation of the disease's etiology. Research funding for endometriosis is limited, with funding from bodies like the National Institutes of Health (NIH) constituting only 0.038% of the 2022 health budget—for a condition that affects 6.5 million women in the US alone and over 190 million worldwide. A major issue is that diagnosis of endometriosis is frequently delayed because surgery is required to histologically confirm the diagnosis. This delay increases symptom intensity, the risk of central and peripheral sensitization and the costs of the disease for the patient and their nation. Current conservative treatments of presumed endometriosis are pain management and birth control. Both of these methods are flawed and can be entirely ineffective for the reduction of patient suffering or improving ability to work, and neither addresses the severe infertility issues or higher risk of certain cancers. Endometriosis research deserves the funding and attention that befits a disease with its substantial prevalence, effects, and economic costs. This funding could improve patient outcomes by introducing less invasive and more timely methods for diagnosis and treatment, including options such as novel biomarkers, nanomedicine, and microbiome alterations.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 This article was submitted to Quality of Life, a section of the journal Frontiers in Global Women's Health Edited by: Lysia Demetriou, University of Oxford, United Kingdom Reviewed by: Pooja Popli, Baylor College of Medicine, United States; Iris Brandes, Hannover Medical School, Germany
ISSN:	2673-5059 2673-5059
DOI:	10.3389/fgwh.2022.902371